These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 28822831)
1. IFNA-AS1 regulates CD4 Luo M; Liu X; Meng H; Xu L; Li Y; Li Z; Liu C; Luo YB; Hu B; Xue Y; Liu Y; Luo Z; Yang H Clin Immunol; 2017 Oct; 183():121-131. PubMed ID: 28822831 [TBL] [Abstract][Full Text] [Related]
2. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4. Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850 [TBL] [Abstract][Full Text] [Related]
3. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles. Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919 [TBL] [Abstract][Full Text] [Related]
4. Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis. Mu L; Sun B; Kong Q; Wang J; Wang G; Zhang S; Wang D; Liu Y; Liu Y; An H; Li H Immunology; 2009 Sep; 128(1 Suppl):e826-36. PubMed ID: 19740344 [TBL] [Abstract][Full Text] [Related]
5. Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model. Gertel-Lapter S; Mizrachi K; Berrih-Aknin S; Fuchs S; Souroujon MC Autoimmun Rev; 2013 Jul; 12(9):894-903. PubMed ID: 23535156 [TBL] [Abstract][Full Text] [Related]
6. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice. Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475 [TBL] [Abstract][Full Text] [Related]
7. Animal models of myasthenia gravis. Christadoss P; Poussin M; Deng C Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092 [TBL] [Abstract][Full Text] [Related]
8. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18. Im SH; Barchan D; Maiti PK; Raveh L; Souroujon MC; Fuchs S FASEB J; 2001 Oct; 15(12):2140-8. PubMed ID: 11641240 [TBL] [Abstract][Full Text] [Related]
9. Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis. Nessi V; Nava S; Ruocco C; Toscani C; Mantegazza R; Antozzi C; Baggi F J Immunol; 2010 Nov; 185(9):5656-67. PubMed ID: 20881192 [TBL] [Abstract][Full Text] [Related]
10. The Long Noncoding RNA IFNG-AS1 Promotes T Helper Type 1 Cells Response in Patients with Hashimoto's Thyroiditis. Peng H; Liu Y; Tian J; Ma J; Tang X; Rui K; Tian X; Mao C; Lu L; Xu H; Jiang P; Wang S Sci Rep; 2015 Dec; 5():17702. PubMed ID: 26634912 [TBL] [Abstract][Full Text] [Related]
11. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines. Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702 [TBL] [Abstract][Full Text] [Related]
12. FOSL1-mediated LINC01566 negatively regulates CD4 Li L; Li D; Jin J; Xu F; He N; Ren Y; Wang X; Tian L; Chen B; Li X; Chen Z; Zhang L; Qiao L; Wang L; Wang J J Neuroinflammation; 2024 Aug; 21(1):197. PubMed ID: 39113081 [TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells. Aricha R; Reuveni D; Fuchs S; Souroujon MC J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998 [TBL] [Abstract][Full Text] [Related]
14. Elevated Expression of the Long Noncoding RNA IFNG-AS1 in the Peripheral Blood from Patients with Rheumatoid Arthritis. Peng H; Ren S; Liu Y; Zhou H; Tang X; Yang J; Tian J; Xu P; Xu H; Wang S J Immunol Res; 2020; 2020():6401978. PubMed ID: 32377535 [TBL] [Abstract][Full Text] [Related]
15. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis. Tüzün E; Allman W; Ulusoy C; Yang H; Christadoss P Ann N Y Acad Sci; 2012 Dec; 1274():133-9. PubMed ID: 23252908 [TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin ameliorates experimental autoimmune myasthenia gravis by regulating CD4 Li Y; Shan Y; Xu L; Chen W; Li Y Int Immunopharmacol; 2024 Sep; 139():112699. PubMed ID: 39024745 [TBL] [Abstract][Full Text] [Related]
17. Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis. Liu X; Ma Q; Qiu L; Ou C; Lin Z; Lu Y; Huang H; Chen P; Huang Z; Liu W Clin Immunol; 2020 Jul; 216():108462. PubMed ID: 32437925 [TBL] [Abstract][Full Text] [Related]
18. [Identification of correlations between numbers of CD4+ CD25+ Treg cells, levels of sera anti-AChR antibodies and transfer growth factor-beta in patients with myasthenia gravis]. Wang HB; Zhang JB; Chui LY Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1036-40. PubMed ID: 18754436 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis. Song J; Xi JY; Yu WB; Yan C; Luo SS; Zhou L; Zhu WH; Lu JH; Dong Q; Xiao BG; Zhao CB Clin Immunol; 2019 Jun; 203():142-153. PubMed ID: 31078707 [TBL] [Abstract][Full Text] [Related]
20. T-bet deficiency decreases susceptibility to experimental myasthenia gravis. Liu R; Hao J; Dayao CS; Shi FD; Campagnolo DI Exp Neurol; 2009 Dec; 220(2):366-73. PubMed ID: 19818352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]